Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
Trials|November 8, 2015
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST)Polly Scutt, Dan Blackburn, Kailash Krishnan, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programmeKamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, et al.
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.
European Heart Journal. Acute Cardiovascular Care|February 20, 2021
MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomesXavier Rossello, Héctor Bueno, Víctor Gil, et al.
Clinical and Translational Science|July 19, 2023
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?Jaap Mandema, Hugh Montgomery, Louis Dron, et al.
Trials|November 26, 2013
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipidsDaniel J Blackburn, Kailash Krishnan, Lydia Fox, et al.
Journal of the American College of Cardiology|September 3, 2021
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled HypertensionMichael Böhm, Konstantinos Tsioufis, David E Kandzari, et al.
Geroscience|May 27, 2026
Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year periodVicente Andrés, Juan M Fernández-Alvira, Beatriz Dorado, et al.
European Heart Journal|January 5, 2019
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trialMichael Böhm, Felix Mahfoud, Raymond R Townsend, et al.
Cardiovascular Diabetology|November 30, 2018
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)Mikhail Kosiborod, Marilia B Gomes, Antonio Nicolucci, et al.
Pageof 25